|
1
|
Adams V, Evans K, Sampson J and Wood J:
Methods and mortality results of a health survey of purebred dogs
in the UK. J Small Anim Pract. 51:512–524. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pinho SS, Carvalho S, Cabral J, Reis CA
and Gärtner F: Canine tumors: A spontaneous animal model of human
carcinogenesis. Transl Res. 159:165–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrander EA, Dreger DL and Evans JM:
Canine cancer genomics: Lessons for canine and human health. Annu
Rev Anim Biosci. 7:449–472. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Davis BW and Ostrander EA: Domestic dogs
and cancer research: A breed-based genomics approach. ILAR J.
55:59–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Katoh H, Shibata T, Kokubu A, Ojima H,
Loukopoulos P, Kanai Y, Kosuge T, Fukayama M, Kondo T, Sakamoto M,
et al: Genetic profile of hepatocellular carcinoma revealed by
array-based comparative genomic hybridization: Identification of
genetic indicators to predict patient outcome. J Hepatol.
43:863–874. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Loukopoulos P, Shibata T, Katoh H, Kokubu
A, Sakamoto M, Yamazaki K, Kosuge T, Kanai Y, Hosoda F, Imoto I, et
al: Genome-wide array-based comparative genomic hybridization
analysis of pancreatic adenocarcinoma: Identification of genetic
indicators that predict patient outcome. Cancer Sci. 98:392–400.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Brien SJ: Pet project. Nature.
438:7402005. View
Article : Google Scholar
|
|
8
|
Theisen A: Microarray-based comparative
genomic hybridization (aCGH). Nature Educ. 1:452008.
|
|
9
|
Dhawan D, Paoloni M, Shukradas S,
Choudhury DR, Craig BA, Ramos-Vara JA, Hahn N, Bonney PL, Khanna C
and Knapp DW: Comparative gene expression analyses identify luminal
and basal subtypes of canine invasive urothelial carcinoma that
mimic patterns in human invasive bladder cancer. PLoS One.
10:e01366882015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Simpson S, Dunning MD, de Brot S,
Grau-Roma L, Mongan NP and Rutland CS: Comparative review of human
and canine osteosarcoma: Morphology, epidemiology, prognosis,
treatment and genetics. Acta Vet Scand. 59:712017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shao YW, Wood GA, Lu J, Tang QL, Liu J,
Molyneux S, Chen Y, Fang H, Adissu H, McKee T, et al: Cross-species
genomics identifies DLG2 as a tumor suppressor in osteosarcoma.
Oncogene. 38:291–298. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Phillips JC, Lembcke L and Chamberlin T: A
novel locus for canine osteosarcoma (OSA1) maps to CFA34, the
canine orthologue of human 3q26. Genomics. 96:220–227. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sapierzyński R and Czopowicz M: The
animal-dependent risk factors in canine osteosarcomas. Pol J Vet
Sci. 20:293–298. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Loukopoulos P and Robinson WF:
Clinicopathological relevance of tumour grading in canine
osteosarcoma. J Comp Pathol. 136:65–73. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Loukopoulos P, Rozmanec M and Sutton RH:
Cytological versus histopathological diagnosis in canine
osteosarcoma. Vet Rec. 157:7842005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Angstadt AY, Thayanithy V, Subramanian S,
Modiano JF and Breen M: A genome-wide approach to comparative
oncology: High-resolution oligonucleotide aCGH of canine and human
osteosarcoma pinpoints shared microaberrations. Cancer Genet.
205:572–587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Thomas R, Scott A, Langford CF, Fosmire
SP, Jubala CM, Lorentzen TD, Hitte C, Karlsson EK, Kirkness E,
Ostrander EA, et al: Construction of a 2-Mb resolution BAC
microarray for CGH analysis of canine tumors. Genome Res.
15:1831–1837. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Phillips JC, Stephenson B, Hauck M and
Dillberger J: Heritability and segregation analysis of osteosarcoma
in the Scottish deerhound. Genomics. 90:354–363. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Meyer FR, Steinborn R, Grausgruber H,
Wolfesberger B and Walter I: Expression of platelet-derived growth
factor BB, erythropoietin and erythropoietin receptor in canine and
feline osteosarcoma. Vet J. 206:67–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wolfesberger B, Fuchs-Baumgartinger A,
Hlavaty J, Meyer FR, Hofer M, Steinborn R, Gebhard C and Walter I:
Stem cell growth factor receptor in canine vs feline osteosarcomas.
Oncol Lett. 12:2485–2492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dimopoulou M, Kirpensteijn J, Moens H and
Kik M: Histologic prognosticators in feline osteosarcoma: A
comparison with phenotypically similar canine osteosarcoma. Vet
Surg. 37:466–471. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fowles JS, Brown KC, Hess AM, Duval DL and
Gustafson DL: Intra- and interspecies gene expression models for
predicting drug response in canine osteosarcoma. BMC
Bioinformatics. 17:932016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Thomas R, Seiser EL, Motsinger-Reif A,
Borst L, Valli VE, Kelley K, Suter SE, Argyle D, Burgess K, Bell J,
et al: Refining tumor-associated aneuploidy through ‘genomic
recoding’ of recurrent DNA copy number aberrations in 150 canine
non-Hodgkin lymphomas. Leuk Lymphoma. 52:1321–1335. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Levsky JM and Singer RH: Fluorescence in
situ hybridization: Past, present and future. J Cell Sci.
116:2833–2838. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Breen M and Modiano JF: Evolutionarily
conserved cytogenetic changes in hematological malignancies of dogs
and humans-man and his best friend share more than companionship.
Chromosome Res. 16:145–154. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Suenaga M, Tomiyasu H, Watanabe M, Ogawa
K, Motegi T, Goto-Koshino Y, Ohno K, Sugano S, Skorupski KA and
Tsujimoto H: Comprehensive analysis of gene expression profiles
reveals novel candidates of chemotherapy resistant factors in
canine lymphoma. Vet J. 228:18–21. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Camus MS, Priest HL, Koehler JW, Driskell
EA, Rakich PM, Ilha MR and Krimer PM: Cytologic criteria for mast
cell tumor grading in dogs with evaluation of clinical outcome. Vet
Pathol. 53:1117–1123. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sledge DG, Webster J and Kiupel M: Canine
cutaneous mast cell tumors: A combined clinical and pathologic
approach to diagnosis, prognosis, and treatment selection. Vet J.
215:43–54. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jark PC, Mundin DB, de Carvalho M, Ferioli
RB, Anai LA, Marchi FA, Rogatto SR, Laufer-Amorim R and
Tinucci-Costa M: Genomic copy number variation associated with
clinical outcome in canine cutaneous mast cell tumors. Res Vet Sci.
111:26–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mochizuki H, Thomas R, Moroff S and Breen
M: Genomic profiling of canine mast cell tumors identifies DNA copy
number aberrations associated with KIT mutations and high
histological grade. Chromosome Res. 25:129–143. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giantin M, Baratto C, Marconato L,
Vascellari M, Mutinelli F, Dacasto M and Granato A: Transcriptomic
analysis identified up-regulation of a solute carrier transporter
and UDP glucuronosyltransferases in dogs with aggressive cutaneous
mast cell tumours. Vet J. 212:36–43. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Strakova A, Ní Leathlobhair M, Wang GD,
Yin TT, Airikkala-Otter I, Allen JL, Allum KM, Bansse-Issa L,
Bisson JL, Castillo Domracheva A, et al: Mitochondrial genetic
diversity, selection and recombination in a canine transmissible
cancer. Elife. 5:e145522016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Decker B, Davis BW, Rimbault M, Long AH,
Karlins E, Jagannathan V, Reiman R, Parker HG, Drögemüller C,
Corneveaux JJ, et al: Comparison against 186 canid whole-genome
sequences reveals survival strategies of an ancient clonally
transmissible canine tumor. Genome Res. 25:1646–1655. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fulkerson CM, Dhawan D, Ratliff TL, Hahn
NM and Knapp DW: Naturally occurring canine invasive urinary
bladder cancer: A complementary animal model to improve the success
rate in human clinical trials of new cancer drugs. Int J Genomics.
2017:65895292017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shapiro SG, Raghunath S, Williams C,
Motsinger-Reif AA, Cullen JM, Liu T, Albertson D, Ruvolo M,
Bergstrom Lucas A, Jin J, et al: Canine urothelial carcinoma:
Genomically aberrant and comparatively relevant. Chromosome Res.
23:311–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Davis B, Schwartz M, Duchemin D, Barrett
JC and Post G: Validation of a multiplexed gene signature assay for
diagnosis of canine cancers from formalin-fixed paraffin-embedded
tissues. J Vet Intern Med. 31:854–863. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Granato A, Giantin M, Ariani P, Carminato
A, Baratto C, Zorzan E, Vascellari M, Bozzato E, Dacasto M and
Mutinelli F: DNA and RNA isolation from canine oncologic
formalin-fixed, paraffin-embedded tissues for downstream ‘-omic’
analyses: Possible or not? J Vet Diagn Invest. 26:117–124. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Breen M: Canine cytogenetics-from band to
basepair. Cytogen Genome Res. 120:50–60. 2008. View Article : Google Scholar
|
|
39
|
Breen M: Update on genomics in veterinary
oncology. Topics Companion Anim Med. 24:113–121. 2009. View Article : Google Scholar
|
|
40
|
Ceciliani F, Roccabianca P, Giudice C and
Lecchi C: Application of post-genomic techniques in dog cancer
research. Mol Biosyst. 12:2665–2679. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jones EA, Cheng Y and Belov K: The origin,
dynamics, and molecular evolution of transmissible cancers. Adv
Genom Genet. 5:317–326. 2015.
|
|
42
|
Ferraresso S, Aricò A, Sanavia T, Da Ros
S, Milan M, Cascione L, Comazzi S, Martini V, Giantin M, Di Camillo
B, et al: DNA methylation profiling reveals common signatures of
tumorigenesis and defines epigenetic prognostic subtypes of canine
diffuse large B-cell lymphoma. Sci Rep. 7:115912017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Courtay-Cahen C, Platt SR, De Risio L and
Starkey MP: Preliminary analysis of genomic abnormalities in canine
meningiomas. Vet Comp Oncol. 6:182–192. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Dickinson PJ, York D, Higgins RJ,
LeCouteur RA, Joshi N and Bannasch D: Chromosomal aberrations in
canine gliomas define candidate genes and common pathways in DOGS
AND HUmans. J Neuropathol Exp Neurol. 75:700–710. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Thomas R, Duke SE, Bloom SK, Breen TE,
Young AC, Feiste E, Seiser EL, Tsai PC, Langford CF, Ellis P, et
al: A cytogenetically characterized, genome-anchored 10-Mb BAC set
and CGH array for the domestic dog. J Hered. 98:474–484. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang G, Wu M, Maloneyhuss MA, Wojcik J,
Durham AC, Mason NJ and Roth DB: Actionable mutations in canine
hemangiosarcoma. PLoS One. 12:e01886672017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Laufer-Amorim R, Fonseca-Alves CE,
Villacis RAR, Linde SAD, Carvalho M, Larsen SJ, Marchi FA and
Rogatto SR: Comprehensive genomic profiling of
androgen-receptor-negative canine prostate cancer. Int J Mol Sci.
20:15552019. View Article : Google Scholar
|
|
48
|
Zapata I, Moraes LE, Fiala EM,
Zaldivar-Lopez S, Couto CG, Rowell JL and Alvarez CE: Risk-modeling
of dog osteosarcoma genome scans shows individuals with
Mendelian-level polygenic risk are common. BMC Genomics.
20:2262019. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Gardner HL, Sivaprakasam K, Briones N,
Zismann V, Perdigones N, Drenner K, Facista S, Richholt R, Liang W,
Aldrich J, et al: Canine osteosarcoma genome sequencing identifies
recurrent mutations in DMD and the histone methyltransferase gene
SETD2. Commun Biol. 2:2662019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Maués T, El-Jaick KB, Costa FB, Freitas
PVS, Moreira AS, Castro L, Ferreira MLG and Ferreira AMR: Could
polymorphisms in ABCB1 gene represent a genetic risk factor for the
development of mammary tumors in dogs? Vet J. 248:58–63. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Korpershoek E, Dieduksman DAER, Grinwis
GCM, Day MJ, Reusch CE, Hilbe M, Fracassi F, Krol NMG, Uitterlinden
AG, de Klein A, et al: Molecular alterations in dog
pheochromocytomas and paragangliomas. Cancers (Basel). 11:6072019.
View Article : Google Scholar
|
|
52
|
Kosack L, Wingelhofer B, Popa A, Orlova A,
Agerer B, Vilagos B, Majek P, Parapatics K, Lercher A, Ringler A,
et al: The ERBB-STAT3 axis drives tasmanian devil facial tumor
disease. Cancer Cell. 14:125–139.e9. 2019. View Article : Google Scholar
|
|
53
|
Singer-Berk MH, Knickelbein KE, Lounsberry
ZT, Crausaz M, Vig S, Joshi N, Britton M, Settles ML, Reilly CM,
Bentley E, et al: Additional evidence for DDB2 T338M as a genetic
risk factor for ocular squamous cell carcinoma in horses. Int J
Genomics. 2019:36109652019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Megquier K, Turner-Maier J, Swofford R,
Kim JH, Sarver AL, Wang C, Sakthikumar S, Johnson J, Koltookian M,
Lewellen M, et al: Comparative genomics reveals shared mutational
landscape in canine hemangiosarcoma and human angiosarcoma. Mol
Cancer Res. 17:2410–2421. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Amin SB, Anderson KJ, Boudreau CE,
Martinez-Ledesma E, Kocakavuk E, Johnson KC, Barthel FP, Varn FS,
Kassab C, Ling X, et al: Comparative molecular life history of
spontaneous canine and human gliomas. Cancer Cell. 37:243–257.e7.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Grimes JA, Prasad N, Levy S, Cattley R,
Lindley S, Boothe HW, Henderson RA and Smith BF: A comparison of
microRNA expression profiles from splenic hemangiosarcoma, splenic
nodular hyperplasia, and normal spleens of dogs. BMC Vet Res.
12:2722016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Mahoney JA, Fisher JC, Snyder SA and Hauck
ML: Feasibility of using gene expression analysis to study canine
soft tissue sarcomas. Mamm Genome. 21:577–582. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Lee KH, Park HM, Son KH, Shin TJ and Cho
JY: Transcriptome signatures of canine mammary gland tumors and its
comparison to human breast cancers. Cancers (Basel). 10:3172018.
View Article : Google Scholar
|
|
59
|
Rahman M, Lai Y, Husna AA, Chen HW, Tanaka
Y, Kawaguchi H, Hatai H, Miyoshi N, Nakagawa T, Fukushima R and
Miura N: Transcriptome analysis of dog oral melanoma and its
oncogenic analogy with human melanoma. Oncol Rep. 43:16–30.
2020.PubMed/NCBI
|
|
60
|
Panchal K, Koringa P, Sabara P, Bhatia D,
Jakhesara S and Joshi C: Expression profiling revealed keratins and
interleukins as potential biomarkers in squamous cell carcinoma of
horn in Indian bullocks (Bos indicus). 3 Biotech. 10:922020.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sabara PH, Jakhesara SJ, Panchal KJ, Joshi
CG and Koringa PG: Transcriptomic analysis to affirm the regulatory
role of long non-coding RNA in horn cancer of Indian zebu cattle
breed Kankrej (Bos indicus). Funct Integr Genomics.
20:75–87. 2020. View Article : Google Scholar : PubMed/NCBI
|
